Evoxac is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Daiichi Sankyo, Inc.. The primary component is Cevimeline Hydrochloride.
Product ID | 63395-201_0d318261-db69-4064-9e34-5cecb91e8b3c |
NDC | 63395-201 |
Product Type | Human Prescription Drug |
Proprietary Name | Evoxac |
Generic Name | Cevimeline Hydrochloride |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 2000-01-12 |
Marketing Category | NDA / NDA |
Application Number | NDA020989 |
Labeler Name | Daiichi Sankyo, Inc. |
Substance Name | CEVIMELINE HYDROCHLORIDE |
Active Ingredient Strength | 30 mg/1 |
Pharm Classes | Cholinergic Muscarinic Agonists [MoA],Cholinergic Receptor Agonist [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2000-01-12 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020989 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 2000-01-12 |
Ingredient | Strength |
---|---|
CEVIMELINE HYDROCHLORIDE | 30 mg/1 |
SPL SET ID: | 0679dd4c-fece-4c6d-b273-2c62237e8973 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
0713-0883 | Evoxac | cevimeline hydrochloride |
63395-201 | Evoxac | cevimeline hydrochloride |
0054-0334 | Cevimeline Hydrochloride | Cevimeline Hydrochloride |
0713-0937 | cevimeline hydrochloride | cevimeline hydrochloride |
16571-657 | Cevimeline Hydrochloride | Cevimeline Hydrochloride |
40032-999 | cevimeline hydrochloride | cevimeline hydrochloride |
43386-999 | cevimeline hydrochloride | cevimeline hydrochloride |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EVOXAC 77641881 3736042 Live/Registered |
DAIICHI SANKYO COMPANY, LIMITED 2008-12-31 |
EVOXAC 75837264 2579509 Live/Registered |
DAIICHI SANKYO COMPANY, LIMITED 1999-11-01 |
EVOXAC 74350561 1980336 Dead/Cancelled |
DAIICHI PHARMACEUTICAL CO., LTD. 1993-01-19 |